Translation and validation of a tool to assess the impact of clinical pharmacists’ interventions
- 111 Downloads
Background The tool CLEO in French language is designed for estimating the potential relevance of pharmacists’ interventions (PIs) in three independent dimensions with regard to process-related, clinical, economic, and humanistic impact. Objective We aimed to translate CLEO into German (CLEOde), to demonstrate its feasibility in daily practice, and to validate the German version. Setting Convenience sample of three Swiss hospitals with established clinical pharmacy services. Method We translated CLEO according to the ISPOR Principles of Good Practice. The potential relevance of PIs performed within a 13-day period of routine clinical pharmacy services was then estimated with CLEOde. Ten clinical pharmacists experienced with CLEOde subsequently completed a 19-item questionnaire to assess user’s agreement on appropriateness, acceptability, feasibility, and precision of the tool. Additionally, each pharmacist evaluated 10 model cases with CLEOde. Main outcome measure User satisfaction; interrater reliability and test–retest reliability. Results CLEOde was used to estimate the potential relevance of 324 PIs. The reported time needed to complete a single estimation was less than 1 min. The use of CLEOde was seen as appropriate, acceptable, feasible, and precise. Interrater reliability was good for the clinical and economic dimensions and was poor for the organisational dimension; test–retest correlation was strong for all three dimensions with excellent to fair reliability. Conclusion We present CLEOde as a validated tool in German language suitable to estimate the potential relevance of PIs. After further refinement of the organisational dimension, CLEOde could provide a qualitative value to quantitative information on PIs.
KeywordsClassification CLEO Tool Clinical pharmacy Clinical relevance Drug-related problems Interrater reliability Pharmacists’ interventions Translation
The study was enabled by funds from the university. No external sources of funding were used to assist in the conduct of this study or the preparation of this article.
Conflicts of interest
The authors declare that they have no conflicts of interest relevant to the content of this study.
- 1.Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.Google Scholar
- 4.World Health Organization WHO. Developing pharmacy practice: a focus on patient care. Geneva 2006.Google Scholar
- 8.The PCNE Classification V 6.2: Classification for drug related problems. Pharmaceutical Care Network Europe Working Conference 2009.Google Scholar
- 9.Cipolle R, Strand L, Morley P. Pharmaceutical care practice: the clinician’s guide. New York: The McGraw-Hilll Companies; 2004.Google Scholar
- 10.Vo TH, Charpiat B, Catoire C, Juste M, Roubille R, Rose FX et al. Tools for assessing potential significance of pharmacist interventions: a systematic review. Drug Saf. 2015.Google Scholar
- 14.Vo TH. Evaluation of the potential impact of pharmacist interventions: development and validation of the CLEO multidimensional tool. https://tel.archives-ouvertes.fr/tel-01315619/document: Grenoble, France: Université Grenoble Alpes; 2015.
- 16.Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8(2):94–104.CrossRefGoogle Scholar
- 17.Breuer J, Seeling M, Barz M, Baldini T, Scholtz K, Spies C. A standardised German translation of the standards for reporting of diagnostic accuracy studies (STARD statement): methodological aspects. J Evid Qual Health Care. 2011;106(7):500–8.Google Scholar
- 20.Ganso M, Areschin S, Lange P, Emser A, Rossler J, Kramer I. Verlasslichkeit eines Klassifikationssystems fur pharmazeutische Interventionen. Krankenhauspharmazie. 2007;28(7):273.Google Scholar
- 22.Hollander M, Wolfe DA, Chicken E. Nonparametric statistical methods. New York: Wiley; 2013.Google Scholar
- 23.RStudio Team. RStudio: integrated development for R. RStudio, Inc., Boston, MA. http://www.RStudio.com/. 2015.
- 24.R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2016.Google Scholar
- 25.Gamer M, Lemon J, Fellows Puspendra Singh I. irr: Various coefficients of interrater reliability and agreement. 2012.Google Scholar